Announcements Trials
Browse Landscape

Status

Completed 16Unknown 9Recruiting 9Not yet recruiting 4Active not recruiting 3Enrolling by invitation 2Terminated 1

Sponsor Class

INDUSTRY 2

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Endocrine 1

Conditions

Neoplasms 33Breast Neoplasms 32Lung Neoplasms 17Colorectal Neoplasms 16Prostatic Neoplasms 13Carcinoma, Non-Small-Cell Lung 13Hematologic Neoplasms 12Stomach Neoplasms 11Pancreatic Neoplasms 11Carcinoma, Hepatocellular 11Diabetes Mellitus 9Melanoma 7Disease 7Colonic Neoplasms 7Pulmonary Disease, Chronic Obstructive 6Cardiovascular Diseases 6Barrett Esophagus 6Urinary Bladder Neoplasms 5Rectal Neoplasms 5Liver Neoplasms 5Leukemia, Myeloid, Acute 5Fatigue 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Pheochromocytoma 4Myasthenia Gravis 4Multiple Myeloma 4Lymphoma, Non-Hodgkin 4Lymphoma 4Lymphatic Metastasis 4Leiomyoma 4

Interventions

somapacitan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Enrolling by invitation × Observational × Diabetes Mellitus, Type 2 × Clear all
NCT06709040 2026-04-06

A Study to Follow Paediatric Participants With Growth Hormone Deficiency Treated With Somapacitan for Long Term Safety Information and Clinical Parameters

Novo Nordisk A/S

Enrolling by invitation
500 enrolled
Endocrine

Diabetes Mellitus, Type 2, Dwarfism, Pituitary, Neoplasms

NCT01511393 2023-06-13

An Active Surveillance Program for Cases of Medullary Thyroid Carcinoma (MTC)

Novo Nordisk A/S

Enrolling by invitation
6,750 enrolled

Diabetes Mellitus, Diabetes Mellitus, Type 2, Carcinoma, Medullary

Data powered by HemOnc (CC BY 4.0) Colophon âš¡